Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP403951.RAilLU-QMrH1p-Ol_22yXikHDGlLnyg3B0I9ylwdszBhU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP403951.RAilLU-QMrH1p-Ol_22yXikHDGlLnyg3B0I9ylwdszBhU130_assertion type Assertion NP403951.RAilLU-QMrH1p-Ol_22yXikHDGlLnyg3B0I9ylwdszBhU130_head.
- NP403951.RAilLU-QMrH1p-Ol_22yXikHDGlLnyg3B0I9ylwdszBhU130_assertion wasGeneratedBy ECO_0000203 NP403951.RAilLU-QMrH1p-Ol_22yXikHDGlLnyg3B0I9ylwdszBhU130_provenance.
- NP403951.RAilLU-QMrH1p-Ol_22yXikHDGlLnyg3B0I9ylwdszBhU130_assertion wasDerivedFrom befree-20140225 NP403951.RAilLU-QMrH1p-Ol_22yXikHDGlLnyg3B0I9ylwdszBhU130_provenance.
- NP403951.RAilLU-QMrH1p-Ol_22yXikHDGlLnyg3B0I9ylwdszBhU130_assertion SIO_000772 19734903 NP403951.RAilLU-QMrH1p-Ol_22yXikHDGlLnyg3B0I9ylwdszBhU130_provenance.
- NP403951.RAilLU-QMrH1p-Ol_22yXikHDGlLnyg3B0I9ylwdszBhU130_assertion evidence source_evidence_literature NP403951.RAilLU-QMrH1p-Ol_22yXikHDGlLnyg3B0I9ylwdszBhU130_provenance.
- NP403951.RAilLU-QMrH1p-Ol_22yXikHDGlLnyg3B0I9ylwdszBhU130_assertion description "[Previous biological studies support roles of CLU and CR1 in the clearance of beta amyloid (Abeta) peptide, the principal constituent of amyloid plaques, which are one of the major brain lesions of individuals with Alzheimer's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP403951.RAilLU-QMrH1p-Ol_22yXikHDGlLnyg3B0I9ylwdszBhU130_provenance.